On the recordApril 4, 2022
Five years ago, when Congress last addressed user fee reauthorization, I asked Dr. Woodcock of the FDA a question on the availability of biosimilar drugs.
Source
congress.govFive years ago, when Congress last addressed user fee reauthorization, I asked Dr. Woodcock of the FDA a question on the availability of biosimilar drugs.
Kaine reflects on past discussions regarding biosimilar drug availability.
Share
More from Tim Kaine
We need critical minerals to build chips for everything from our smartphones to our national defense apparatus.
But they're finally listening to them. And nothing makes you listen as much as an election staring you in the face.
Everywhere we go throughout the Commonwealth, we hear the same thing: Virginians cannot afford this Administration’s disastrous policies.
Rolling back efforts to clean up the Bay is dangerous not just for our environment but for our economy.